tiprankstipranks
Advertisement
Advertisement

TOVX Stock Latest News

Theriva Biologics highlights promising VCN-01 Phase 1 results
Company AnnouncementsTheriva Biologics highlights promising VCN-01 Phase 1 results
4d ago
8K
TOVX
Theriva Biologics Faces Quorum Issue Delaying Warrant Vote
PremiumCompany Announcements
Theriva Biologics Faces Quorum Issue Delaying Warrant Vote
9d ago
8K
TOVX
3 Penny Stocks to Watch Now, 4/21/26
PremiumMarket News
3 Penny Stocks to Watch Now, 4/21/26
2M ago
PBM
ENVB
Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data
PremiumCompany Announcements
Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data
2M ago
8K
TOVX
Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial
PremiumThe Fly
Theriva Biologics to present additional data on Phase 2b VCN-01Clinical Trial
2M ago
TOVX
Theriva Biologics Faces Delays in Warrant Approval Meeting
PremiumCompany AnnouncementsTheriva Biologics Faces Delays in Warrant Approval Meeting
2M ago
8K
TOVX
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
Premium
The Fly
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
3M ago
TOVX
Theriva Biologics upgraded to Buy from Hold at Maxim
Premium
The Fly
Theriva Biologics upgraded to Buy from Hold at Maxim
3M ago
TOVX
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
PremiumCompany Announcements
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
3M ago
8K
TOVX
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
PremiumThe Fly
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
3M ago
TOVX
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
PremiumThe Fly
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
3M ago
TOVX
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
PremiumThe Fly
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
3M ago
TOVX
Theriva Biologics sees cash runway into 1Q27
PremiumThe FlyTheriva Biologics sees cash runway into 1Q27
3M ago
TOVX
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
Premium
Company Announcements
Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
4M ago
8K
TOVX
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
Premium
The Fly
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
4M ago
TOVX
Theriva Biologics Faces Delay in Warrant Approval Meeting
PremiumCompany Announcements
Theriva Biologics Faces Delay in Warrant Approval Meeting
4M ago
8K
TOVX
Theriva Biologics advances VCN-01 toward Phase 3 trial
PremiumCompany Announcements
Theriva Biologics advances VCN-01 toward Phase 3 trial
5M ago
8K
TOVX
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
PremiumCompany Announcements
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
6M ago
8K
TOVX
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
PremiumThe Fly
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
6M ago
TOVX
Theriva Biologics Reschedules Special Stockholder Meeting
PremiumCompany AnnouncementsTheriva Biologics Reschedules Special Stockholder Meeting
6M ago
8K
TOVX
Theriva Biologics Advances Oncology Pipeline with VCN-01
Premium
Company Announcements
Theriva Biologics Advances Oncology Pipeline with VCN-01
7M ago
TOVX
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
Premium
The Fly
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
7M ago
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >